Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy

被引:108
作者
Qian, Haoran [1 ]
Yang, Yi [2 ,3 ]
Wang, Xianfa [1 ]
机构
[1] Zhejiang Univ, Dept Gen Surg, Inst Microinvas Surg, Sir Run Run Shaw Hosp,Med Coll, Hangzhou 310016, Zhejiang, Peoples R China
[2] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou 310027, Peoples R China
[3] Zhejiang Univ, Dept Biomed Engn, Key Lab Biomed Engn, Minist Educ, Hangzhou 310027, Peoples R China
关键词
Curcumin; Adriamycin (doxorubicin); Hepatoma G2 cells; Mitochondria; Apoptosis; Autophagy; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CANCER-CELLS; CLINICAL-TRIALS; DOXORUBICIN; COMBINATION; CISPLATIN; LUNG; MICE; DNA;
D O I
10.1016/j.ejps.2011.04.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cancer killer in the world. Adriamycin (ADM) is a widely used anti-cancer drug. However, the efficacy is low since high dose of ADM causes toxicity to normal tissues. Curcumin, derived from turmeric (Curcumin longa), has shown its therapeutic potential against HCC. Here, we aim to investigate the effects of curcumin combined with ADM on human liver-derived Hepatoma G2 (HepG2) cell death. We found that combination treatment of curcumin with ADM significantly decreased the number of viable cells as compared to single agent treatment. Hoechst staining demonstrated that apoptotic cell death occurred upon curcumin and ADM treatment. The decreased Bcl-2/Bax protein ratio and the activation of caspase-3 were also detected. In addition, curcumin plus ADM led to mitochondrial fragmentation, the reduction of mitochondrial membrane potential, as well as the activation of autophagy. These findings suggest the combined treatment of curcumin with ADM might be an optional chemotherapeutic method for HCC. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 33 条
[1]  
Aggarwal BB, 2003, ANTICANCER RES, V23, P363
[2]  
BRISTOW MR, 1978, CANCER TREAT REP, V62, P873
[3]  
Campbell Frederick C, 2005, Future Oncol, V1, P405, DOI 10.1517/14796694.1.3.405
[4]   Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells [J].
Chaudhury, LR ;
Hruska, KA .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (01) :1-5
[5]   Activation of PPARγ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR [J].
Chen, AP ;
Xu, JY .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (03) :G447-G456
[6]   Curcumin inhibited the arylamines N-acetyltransferase activity, gene expression and DNA adduct formation in human lung cancer cells (A549) [J].
Chen, YS ;
Ho, CC ;
Cheng, KC ;
Tyan, YS ;
Hung, CF ;
Tan, TW ;
Chung, JG .
TOXICOLOGY IN VITRO, 2003, 17 (03) :323-333
[7]   Hepatocellular carcinoma: Recent trends in the United States [J].
El-Serag, HB .
GASTROENTEROLOGY, 2004, 127 (05) :S27-S34
[8]  
Jiang MC, 1996, ONCOGENE, V13, P609
[9]   LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing [J].
Kabeya, Y ;
Mizushima, N ;
Uero, T ;
Yamamoto, A ;
Kirisako, T ;
Noda, T ;
Kominami, E ;
Ohsumi, Y ;
Yoshimori, T .
EMBO JOURNAL, 2000, 19 (21) :5720-5728
[10]   4-QUINOLONES CAUSE A SELECTIVE LOSS OF MITOCHONDRIAL-DNA FROM MOUSE L1210 LEUKEMIA-CELLS [J].
LAWRENCE, JW ;
DARKINRATTRAY, S ;
XIE, F ;
NEIMS, AH ;
ROWE, TC .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, 51 (02) :165-174